2025-521872-69-00RecruitingPhase 1
OMTX705-006 Phase 1b
Source: EU CTIS (euclinicaltrials.eu) · Last updated 11 Feb 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 54 (estimated)
- First submitted
- 12 Jun 2025
- Start date
- 28 Oct 2025
- Lead sponsor
- Oncomatryx Biopharma S.A.
- Diseases
- Pancreatic cancer
- EU CT number
- 2025-521872-69-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 54
- 6 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (6)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Universitari Vall d'Hebron | Barcelona | Spain | Recruiting |
| Hospital Universitario Donostia | Donostia | Spain | Recruiting |
| Institut Catala D'oncologia | L'Hospitalet de Llobregat | Spain | Recruiting |
| Hospital Universitario 12 de Octubre | Madrid | Spain | Recruiting |
| Clínica Universidad de navarra | Pamplona | Spain | Recruiting |
| Complexo Hospitalario Universitario De Santiago | Santiago de Compostela | Spain | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.